Erratum: A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease First (Int J Epidemiol (2017) 46: 6 (1924-1939) DOI: 10.1093/ije/dyx202);A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages 1924-1939

  Moon, Katherine A ^a   Oberoi, Shilpi ^b   Barchowsky, Aaron ^b   Chen, Yu ^c   Guallar, Eliseo ^a   Nachman, Keeve E ^a   Rahman, Mahfuzar ^d   Sohel, Nazmul ^e   D'Ippoliti, Daniela ^f   Wade, Timothy J ^g   James, Katherine A ^h   Farzan, Shohreh F ⁱ   Karagas, Margaret R ^j   Ahsan, Habibul ^k   Navas Acien, Ana ^a,l  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^e MCMASTER UNIVERSITY   (Canada)

^f DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^g U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j DARTMOUTH MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

^l Department of Medicine   (United States)

more..

Author keywords

Arsenic; Cardiovascular disease; Dose response; Meta analysis

Indexed keywords

ARSENIC; DRINKING WATER;

ARSENIC; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; DISEASE INCIDENCE; DOSE-RESPONSE RELATIONSHIP; DRINKING WATER; HEALTH RISK; META-ANALYSIS; MORTALITY; POLLUTION EXPOSURE; RISK ASSESSMENT; STROKE; WATER QUALITY;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; DOSE RESPONSE; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM EXPOSURE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CHEMISTRY; ENVIRONMENTAL EXPOSURE; INCIDENCE; META ANALYSIS; RISK FACTOR; TOXICITY; WATER POLLUTANT;

ARSENIC; CARDIOVASCULAR DISEASES; DRINKING WATER; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; WATER POLLUTANTS, CHEMICAL;

EID: 85039549688     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/IJE/DYY073     Document Type: Erratum

References (88)

1. Naujokas MF, Anderson B, Ahsan H et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 2013;121: 295-302
2. U.S. Environmental Protection Agency. Fiscal Year 2011 Drinking Water and Ground Water Statistics. EPA 816-R-13-003 March 2013. 2013. http://water.epa.gov/scitech/datait/data bases/drink/sdwisfed/howtoaccessdata.cfm (18 November 2015, date last accessed)
3. Ayotte JD, Gronberg JM, Apodaca LE. Trace Elements and Radon in Groundwater Across the United States, 1992-2003. Scientific Investigations Report 2011-5059. 2011. http://pubs. usgs.gov/sir/2011/5059/pdf/sir2011-5059_report-covers_508. pdf (18 November 2015, date last accessed)
4. Hutson SS, Barber NL, Kenney JF, Linsey KS, Lumia DS, Maupin MA. Estimated Use of Water in the United States in 2000:U.S. Geological Survey Circular 1268. 2004.:http://pubs.usgs.gov/circ/2004/circ1268/(18 November 2015, date last accessed)
5. Stanton BA, Caldwell K, Congdon CB et al. MDI Biological Laboratory Arsenic Summit: Approaches to Limiting Human Exposure to Arsenic. Curr Environ Health Rep 2015;2:329-37
6. National Research Council. Arsenic in Drinking Water. Subcommittee on Arsenic in Drinking Water, National Research Council. Washington DC: National Academy Press, 1999
7. Nachman KE, Baron PA, Raber G, Francesconi KA, Navas-Acien A, Love DC. Roxarsone, inorganic arsenic, and other arsenic species in chicken: a US-based market basket sample. Environ Health Perspect 2013;121:818-24
8. Xue J, Zartarian V, Wang SW, Liu SV, Georgopoulos P. Probabilistic modeling of dietary arsenic exposure and dose and evaluation with 2003-2004 NHANES Data. Environ Health Perspect 2010;118:345-50
9. Gilbert-Diamond D, Cottingham KL, Gruber JF et al. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci U S A 2011;108:20656-60
10. Navas-Acien A, Nachman KE. Public health responses to arsenic in rice and other foods. JAMA Intern Med 2013;173:1395-96
11. National Research Council. Critical Aspects of EPA's IRIS Assessment of Inorganic Arsenic: Interim Report. Washington DC: National Academies Press, 2013
12. James KA, Byers T, Hokanson JE, Meliker JR, Zerbe GO, Marshall JA. Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents. Environ Health Perspect 2015;123:128-34
13. Moon KA, Guallar E, Umans JG et al. Low to moderate arsenic exposure and incident cardiovascular disease: the Strong Heart Study. Ann Intern Med 2013;159 649-59
14. Farzan SF, Chen Y, Rees JR, Zens MS, Karagas MR. Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US populationbased study. Toxicol Appl Pharmacol 2015;287:93-97
15. Wade TJ, Xia Y, Mumford J et al. Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control study. Environ Health 2015;14:35
16. D'Ippoliti D, Santelli E, De Sario M, Scortichini M, Davoli M, Michelozzi P. Arsenic in drinking water and mortality for cancer and chronic diseases in central Italy, 1990-2010. PLoS One 2015;10:e0138182
17. Chen Y, Graziano JH, Parvez F et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011;342:d2431
18. Chen Y, Wu F, Liu M et al. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 2013;121: 832-38
19. U.S. Environmental Protection Agency. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Federal Register 2001:6976-7066
20. National Research Council. Arsenic in Drinking Water. 2001 Update. Washington DC: National Academy Press; 2001
21. National Research Council. Science and Decisions: Advancing Risk Assessment. Washington DC: National Academies Press, 2009
22. National Research Council. Review of EPA's Integrated Risk Information System (IRIS) Process. Washington, DC: National Academies Press, 2014
23. Schmidt CW. Low-dose arsenic: in search of a risk threshold. Environ Health Perspect;2014;122:A130-34
24. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66-73
25. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 2012;14:542-55
26. Navas-Acien A, Sharrett AR, Silbergeld EK et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-49
27. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoSMed 2009;6:e1000097
28. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12
29. Afridi HI, Kazi TG, Kazi N et al. Association of environmental toxic elements in biological samples of myocardial infarction patients at different stages. Biol Trace Elem Res 2011;141:26-40
30. Afridi HI, Kazi TG, Kazi N et al. Evaluation of toxic elements in scalp hair samples of myocardial infarction patients at different stages as related to controls. Biol Trace Elem Res 2010;134: 1-12
31. Liao YT, Chen CJ, Li WF et al. Elevated lactate dehydrogenase activity and increased cardiovascular mortality in the arsenicendemic areas of southwestern Taiwan. Toxicol Appl Pharmacol 2012;262:232-37
32. WuMM, Chiou HY, Chen CL et al. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Toxicol Appl Pharmacol 2010;248:226-33
33. Wang C-H, Chen C-L, Hsu L-I et al. Chronic Arsenic Exposure Increases Mortality from Ischemic Heart Disease and Stroke: A Follow-up Study on 26, 851 Residents in Taiwan. 2005. https://www.researchgate.net/publication/251423451_Chronic_Arsenic _Exposure_Increases_Mortality_from_Ischemic_Heart_Disease_ and_Stroke_A_Follow-up_Study_on_26851_Residents_in_ Taiwan (18 November 2015, date last accessed)
34. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997;28: 1717-23
35. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and longterm arsenic exposure. Arterioscler Thromb Vasc Biol 1996;16: 504-10
36. Wade TJ, Xia Y, Wu K et al. Increased mortality associated with well-water arsenic exposure in Inner Mongolia, China. Int J Environ Res Public Health 2009;6:1107-23
37. Rahman M, Sohel N, Yunus M et al. A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults. BMC Public Health 2014;14:174
38. Hartemink N, Boshuizen HC, Nagelkerke NJD, Jacobs MAM, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 2006; 163:1042-52
39. Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp (1 May 2014, date last accessed)
40. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A metaanalysis of alcohol consumption in relation to risk of breast cancer. JAMA 1988;260:652-56
41. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 1994;140: 290-96
42. Karagas MR, Tosteson TD, Blum J et al. Measurement of low levels of arsenic exposure:a comparison of water and toenail concentrations. Am J Epidemiol 2000;152:84-90
43. Smith AH, Ercumen A, Yuan Y, Steinmaus CM. Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J Expo Sci Environ Epidemiol 2009;19:343-48
44. Calderon RL, Hudgens E, Le XC, Schreinemachers, D Thomas DJ. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect 1999;107: 663-67
45. Liu Q, Cook NR, Bergström A, Hsieh C-C. A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data. Comput Stat Data Anal 2009;53: 4157-67
46. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to metaanalysis. Am J Epidemiol 1992;135:1301-39
47. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 2010;29:1282-97
48. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
49. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 2012;31:3805-20
50. Discacciati A, Crippa A, Orsini N. Goodness of fit tools for doseresponse meta-analysis of binary outcomes. Res Synth Methods 2017;8:149-60
51. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315: 629-34
52. Baujat B, Mahé C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a metaanalysis of 65 trials. Stat Med 2002;21:2641-52
53. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating metaanalyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954-70
54. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130: 1123-32
55. Medrano MAJ, Boix R, Pastor-Barriuso R et al. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 2010;110:448-54
56. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 1994;49:418-27
57. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011
58. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2015
59. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York, NY: Springer, 2009
60. Sohel N, Persson LA, RahmanMet al. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology 2009;20:824-30
61. Wang C-H, Hsiao CK, Chen C-L et al. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 2007;222: 315-26
62. Tsuji JS, Perez V, Garry MR, Alexander DD. Association of lowlevel arsenic exposure in drinking water with cardiovascular disease: A systematic review and risk assessment. Toxicology 2014; 323:78-94
63. Chen Y, Factor-Litvak P, Howe GR et al. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, crosssectional study. Am J Epidemiol 2007;165:541-52
64. Tseng CH, Huang YK, Huang YL et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 2005;206:299-308
65. Huang Y-L, Hsueh Y-M, Huang Y-K, Yip P-K, Yang M-H, Chen C-J. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosishyperendemic areas in southwestern Taiwan. Sci Total Environ 2009;407:2608-14
66. Hsieh Y-C, Lien L-M, Chung W-T et al. Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ Res 2011;111: 804-10
67. Wu F, Jasmine F, Kibriya MG et al. Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh. Toxicol Appl Pharmacol 2014;276:195-203
68. Gribble MO, Howard BV, Umans JG et al. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epkdemiol 2012;176:865-74
69. Kuo CC, Howard BV, Umans JG et al. Arsenic exposure, arsenic metabolism, and incident diabetes in the Strong Heart Study. Diabetes Care 2015;38:620-27
70. Marchiset-Ferlay N, Savanovitch C, Sauvant-Rochat MP. What is the best biomarker to assess arsenic exposure via drinking water? Environ Int 2012;39:150-71
71. Hughes MF. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 2006;114:1790-96
72. Pomroy C, Charbonneau SM, McCullough RS, Tam GK. Human retention studies with 74As. Toxicol Appl Pharmacol 1980;53:550-56
73. Cullen WR, Reimer KJ. Arsenic speciation in the environment. Chem Rev 1989;89:713-64
74. Steinmaus CM, Yuan Y, Smith AH. The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res 2005;99:164-68
75. Karagas MR, Le, CX MorrisS et al. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 2001;14:171-75
76. Ryan PB, Huet N, MacIntosh DL. Longitudinal investigation of exposure to arsenic, cadmium, and lead in drinking water. Environ Health Perspect 2000;108:731-35
77. Button M, Jenkin GR, Harrington CF, Watts MJ. Human toenails as a biomarker of exposure to elevated environmental arsenic. J Environ Monit 2009;11:610-17
78. Slotnick MJ, Nriagu JO. Validity of human nails as a biomarker of arsenic and selenium exposure: A review. Environ Res 2006; 102:125-39
79. Cubadda F, Jackson BP, Cottingham KL, Van Horne YO, Kurzius-Spencer M. Human exposure to dietary inorganic arsenic and other arsenic species: State of knowledge, gaps and uncertainties. Sci Total Environ 2017;579:1228-39
80. Navas-Acien A, Umans JG, Howard BV et al. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect 2009;117:1428-33
81. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993;4:218-28
82. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010; 340:c221
83. Focazio MJ, Welch AH, Watkins SA, Helsel DR, Horn MA. A Retrospective Analysis on the Occurrence of Arsenic in Ground-Water Resources of the United States and Limitations in Drinking-Water-Supply Characterizations. 2000. http://pubs. usgs.gov/wri/wri994279/pdf/wri994279.pdf (18 November 2015, date last accessed)
84. DeSimone LA.Quality ofWater FromDomesticWells in Principal Aquifers of the United States, 1991-2004:U.S. Geological Survey Scientific Investigations Report 2008-5227. 2009. http://pubs. usgs.gov/sir/2008/5227 (18 November 2015, date last accessed)
85. EFSA (European Food Safety Authority).Dietary exposure to inorganic arsenic in the European population. EFSA J 2014;12: 3597
86. Cottingham KL, Karimi R, Gruber JF et al. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water. Nutr J 2013;12:149
87. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Karagas MR. Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect 2012;120:1418-24
88. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics-2014 update. A report from the American Heart Association. Circulation 2014;129:e28-92